# Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)

> **NCT05191940** · NA · RECRUITING · sponsor: **EBG MedAustron GmbH** · enrollment: 30 (estimated)

## Conditions studied

- Pancreas Cancer

## Interventions

- **RADIATION:** Particle-therapy using protons or carbon ions
- **DIAGNOSTIC_TEST:** Blood sampling
- **DIAGNOSTIC_TEST:** Magnetic resonance imaging
- **DIAGNOSTIC_TEST:** Computertomography
- **DIAGNOSTIC_TEST:** 18-F-FluorDesoxyGlukose Positron Emission Tomography-Computer Tomography (18F-FDG-PET-CT)

## Key facts

- **NCT ID:** NCT05191940
- **Lead sponsor:** EBG MedAustron GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-16
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05191940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05191940, "Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05191940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*